Certified by Founder Lodge
Abselion
United Kingdom - Cambridge, England
START UP
1 Disclosed Funding Rounds $8,412,690
0 Participating Investments
-
Founded date
2017
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Our mission at Abselion is to simplify protein quantification for the scientists making crucial decisions to accelerate the development of biotherapeutics. Our tools help researchers to devel
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 10 ,2024 | Series A | $8,412,690 |
BGF
the Untitled Ventures
M Ventures(Netherlands)
BioProcess360 Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
